Atlas Trials

A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients

Clinical trial NCT05747768 · UNKNOWN

Trial details

NCT number
NCT05747768
Sponsor
Peking University Third Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2022-07-15
Primary completion
2024-06-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.